An Expanded Access Open-Label, Compassionate Use Protocol of Remune in HIV-1-Infected Adults With CD4 Count Less Than 300 Cells/Ml
NACompletedINTERVENTIONAL
Timeline
Start Date
Not specified
Conditions
HIV Infections
Interventions
BIOLOGICAL
HIV-1 Immunogen
Trial Locations (1)
92008
Immune Response Corp, Carlsbad
All Listed Sponsors
lead
The Immune Response Corporation
INDUSTRY
NCT00002172 - An Expanded Access Open-Label, Compassionate Use Protocol of Remune in HIV-1-Infected Adults With CD4 Count Less Than 300 Cells/Ml | Biotech Hunter | Biotech Hunter